Therapy Areas: Allergy
8 April 2020 - - The US Food and Drug Administration has approved the Biologics License Application 2061 for Sevenfact, a new recombinant coagulation Factor VIIa [coagulation factor VIIa (recombinant)...
7 April 2020 - Biotechnology company Ridgeback Biotherapeutics LP said on Monday that it has received US Food and Drug Administration (FDA) approval to initiate human clinical testing of investigation...
27 March 2020 - Human health company Evolve BioSystems Inc said on Thursday that it plans to conduct a clinical study in children at risk for developing atopic dermatitis in partnership with Janssen R...
25 March 2020 - Molecular diagnostic test provider Mesa Biotech announced on Tuesday the receipt of US Food & Drug Administration (FDA) Emergency Use Authorization (EUA) for its Accula SARS-CoV-2 ...
20 March 2020 - Molecular diagnostic company Mesa Biotech Inc reported on Thursday the receipt of a USD561,000 contract from the US Department of Health and Human Services (HHS) Biomedical Advanced Re...
13 March 2020 - Healthcare companies AbCellera and Eli Lilly and Company (NYSE:LLY) reported on Thursday the signing of an agreement to co-develop antibody products for the treatment and prevention of...